These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1606338)

  • 1. Treatment of valproic acid-associated hepatic failure with orthotopic liver transplantation.
    Bell EA; Shaefer MS; Markin RS; Wood RP; Langnas AN; Stratta RJ; Shaw BW
    Ann Pharmacother; 1992 Jan; 26(1):18-21. PubMed ID: 1606338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fatal hepatic necrosis during treatment with sodium valproate].
    Miguil M; Chlihi A; Mjahed K; Sarf I; Moutawakkil S; Benaguida M
    Cah Anesthesiol; 1995; 43(3):325-6. PubMed ID: 7583902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults.
    König SA; Schenk M; Sick C; Holm E; Heubner C; Weiss A; König I; Hehlmann R
    Epilepsia; 1999 Jul; 40(7):1036-40. PubMed ID: 10403231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fatal hepatic failure in a normally developed 5-year-old boy caused by VPA monotherapy].
    König S; Scheffner D; Rauterberg-Ruland I; Kochen W; Hofmann WJ; Wokittel E; Schick U
    Monatsschr Kinderheilkd; 1987 Jun; 135(6):310-3. PubMed ID: 3112563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Valproate-associated hepatotoxicity--pathogenesis, clinical aspects, therapy and prevention].
    Siemes H; Nau H
    Klin Padiatr; 1991; 203(6):411-9. PubMed ID: 1758143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal hepatocerebral syndrome in siblings discordant for exposure to valproate.
    Lenn NJ; Ellis WG; Washburn ER; Ruebner B
    Epilepsia; 1990; 31(5):578-83. PubMed ID: 2119302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute fatal liver insufficiency due to valproic acid therapy].
    Binek J; Hany A; Egloff B; Heer M
    Schweiz Med Wochenschr; 1991 Feb; 121(7):228-33. PubMed ID: 2008603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid-induced encephalopathy in very long course treated patients.
    Rousseau MC; Montana M; Villano P; Catala A; Blaya J; Valkov M; Allouard Y; Bugni E
    Brain Inj; 2009 Nov; 23(12):981-4. PubMed ID: 19831495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate-induced coma: case report and literature review.
    Duarte J; Macias S; Coria F; Fernandez E; Clavería LE
    Ann Pharmacother; 1993 May; 27(5):582-3. PubMed ID: 8347908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-fatal and fatal liver failure associated with valproic acid.
    Schmid MM; Freudenmann RW; Keller F; Connemann BJ; Hiemke C; Gahr M; Kratzer W; Fuchs M; Schönfeldt-Lecuona C
    Pharmacopsychiatry; 2013 Mar; 46(2):63-8. PubMed ID: 22915484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation for disulfiram-induced hepatic failure.
    Rabkin JM; Corless CL; Orloff SL; Benner KG; Flora KD; Rosen HR; Olyaei AJ
    Am J Gastroenterol; 1998 May; 93(5):830-1. PubMed ID: 9625138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic-acid-induced pancreatitis. Case report and review of the literature.
    Binek J; Hany A; Heer M
    J Clin Gastroenterol; 1991 Dec; 13(6):690-3. PubMed ID: 1761843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India.
    Mehndiratta MM; Mehndiratta P; Phul P; Garg S
    J Pak Med Assoc; 2008 Nov; 58(11):627-31. PubMed ID: 19024136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate increases the risk of valproic acid-induced encephalopathy.
    Noh Y; Kim DW; Chu K; Lee ST; Jung KH; Moon HJ; Lee SK
    Epilepsia; 2013 Jan; 54(1):e1-4. PubMed ID: 22691153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate-induced hepatic failure in a case of cytochrome c oxidase deficiency.
    Chabrol B; Mancini J; Chretien D; Rustin P; Munnich A; Pinsard N
    Eur J Pediatr; 1994 Feb; 153(2):133-5. PubMed ID: 8157021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Velioğlu SK; Gazioğlu S
    Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endstage liver disease associated with nitrofurantoin requiring liver transplantation.
    Hebert MF; Roberts JP
    Ann Pharmacother; 1993 Oct; 27(10):1193-4. PubMed ID: 8251685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dispensability of Annual Laboratory Follow-Up After More than 2 Years of Valproic Acid Use: A Systematic Review.
    Meijboom RW; Grootens KP
    CNS Drugs; 2017 Nov; 31(11):939-957. PubMed ID: 29214384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate hepatotoxicity syndrome: hypotheses of pathogenesis.
    Stephens JR; Levy RH
    Pharm Weekbl Sci; 1992 Jun; 14(3A):118-21. PubMed ID: 1502010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal fulminant hepatic failure due to sodium valproate in an adolescent.
    Puri AS; Sharma BC; Khan EM; Saraswat VA
    Indian Pediatr; 1994 Feb; 31(2):207-10. PubMed ID: 7875849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.